AbbVie Inc.

Selected Financial Data
since 2012

Main items of AbbVie Inc.'s financial statements.

• Income Statement
• Assets
• Liabilities and Stockholders' Equity
• Statement of Cash Flows
• Per Share Data

Enterprise Value to EBITDA (EV/EBITDA)

To calculate EBITDA analysts start with net earnings. To that earnings number, interest, taxes, depreciation, and amortization are added. EBITDA as a pre-interest number is a flow to all providers of capital.

• Earnings before Interest, Tax, Depreciation and Amortization (EBITDA)
• EV to EBITDA Ratio, Current
• EV to EBITDA Ratio, Historical

Present Value of Free Cash Flow to Equity (FCFE)

The FCFE valuation approach estimates the value of equity as the present value of future FCFE discounted at the required rate of return on equity.

• Intrinsic Stock Value (Valuation Summary)
• Required Rate of Return (r)
• FCFE Growth Rate (g)

Price to Sales (P/S)
since 2012

An rationale for the P/S ratio is that sales, as the top line in an income statement, are generally less subject to distortion or manipulation than other fundamentals such as EPS or book value. Sales are also more stable than earnings and never negative.

• Calculation
• Comparison to Competitors
• Comparison to Pharmaceuticals & Biotechnology Sector
• Comparison to Health Care Industry

Income Statement

The income statement (statement of earnings) reports on the performance of AbbVie Inc., the result of its operating activities.

Common-Size Statement of Financial Position, Liabilities and Stockholders' Equity
Quarterly Data

Liabilities and stockholders' equity components shown as percentage of total liabilities and stockholders' equity.